OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 28, 2021
The launch of HiScreen Fibro PrismA, the company’s newest product for early mAb purification process development strengthens Cytiva’s new fiber-based Protein A platform.
January 02, 2021
The development of an innovative purification process simplifies downstream processing for biologics.
December 02, 2020
Establishing an automated inline dilution system can potentially ease bottlenecking delays resulting from higher upstream yields.
Viral clearance processes and guidance must evolve along with newer biotherapeutic modalities.
November 02, 2020
Continuous SEC was shown to increase productivity with the same product quality and yield.
October 22, 2020
The 6th-generation Eclipse FFF system handles analytes such as proteins, polymers, viruses, gene vectors, and liposomal drug nanoparticles.
October 01, 2020
A balance must be achieved between debris and impurity removal and maximizing product quality and yield.
September 01, 2020
As technology matures, inefficiencies and process limitations in downstream process chromatography are improved.
August 02, 2020
New therapeutics modalities and the need for greater process efficiency are driving technology development.
February 01, 2020
Developers need to transcend the limits of existing separation technologies, to maximize vector recovery while preserving therapeutic potency.